{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:28Z","timestamp":1792532368711,"version":"4.5.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To characterize longitudinal patterns of intraretinal (IRF) and subretinal fluid (SRF) dynamics using artificial intelligence\u2013assisted optical coherence tomography (OCT) biomarker quantification and to evaluate their association with long-term visual outcomes in eyes with central retinal vein occlusion (CRVO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Patients with previously treatment-na\u00efve CRVO and a documented 24-month follow-up were retrospectively included. All eyes received intravitreal aflibercept administered according to a treat-and-extend protocol. Spectral-domain OCT scans were analyzed at baseline and after 3 and 24 months. IRF and SRF volumes were quantified using RetinAI Discovery OCT Biomarker Detector (Ikerian AG). Linear regression models were used to assess the association between fluid volumes and 24-month corrected distance visual acuity (CDVA). Patients were clustered according to their IRF trajectories over time to identify distinct fluid-response phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 173 patients, 64 eyes (64 patients) were included. Baseline IRF and SRF volumes showed no significant association with 24-month CDVA. Cluster analysis of longitudinal IRF trajectories identified four distinct fluid-response patterns. Eyes with low or rapidly resolving IRF achieved the best long-term visual outcomes (median CDVA 73 letters), whereas those with persistent or recurrent IRF showed poorer outcomes (median 53 letters;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008). Early IRF resolution tended to predict superior visual recovery at 24 months.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Artificial intelligence\u2013based volumetric OCT analysis suggests that distinct retinal fluid trajectories in CRVO may have prognostic implications for long-term visual acuity, although these findings are preliminary and require validation. Dynamic IRF resolution patterns may be more informative than static fluid volumes for predicting functional outcomes after anti\u2013vascular endothelial growth factor therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000004932","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T17:00:31Z","timestamp":1785258031000},"page":"2026-2032","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["AI-ASSISTED OCT BIOMARKER QUANTIFICATION REVEALS DISTINCT RETINAL FLUID TRAJECTORIES IN CENTRAL RETINAL VEIN OCCLUSION"],"prefix":"10.1097","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-312X","authenticated-orcid":false,"given":"Klemens P.","family":"Kaiser","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Goethe-University Frankfurt, Frankfurt am Main, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Steiner","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Jaggi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Ay","sequence":"additional","affiliation":[{"name":"Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, Austria; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Zinkernagel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-9870","authenticated-orcid":false,"given":"Florian M.","family":"Heussen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Inselspital, University Hospital Bern, Bern, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261020","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/archopht.1996.01100140443012","article-title":"Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study","volume":"114","author":"Mitchell","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"R2-20261020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ophtha.2010.04.019","article-title":"Natural history of visual outcome in central retinal vein occlusion","volume":"118","author":"Hayreh","year":"2011","journal-title":"Ophthalmology"},{"key":"R3-20261020","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ophtha.2010.02.022","article-title":"Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study","volume":"117","author":"Brown","year":"2010","journal-title":"Ophthalmology"},{"key":"R4-20261020","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2147\/OPTH.S140665","article-title":"Integrated results from the COPERNICUS and GALILEO studies","volume":"11","author":"Pielen","year":"2017","journal-title":"Clin Ophthalmol"},{"key":"R5-20261020","doi-asserted-by":"crossref","first-page":"752048","DOI":"10.3389\/fphar.2021.752048","article-title":"Comparative efficacy of pharmacotherapy for macular edema secondary to retinal vein occlusion: a network meta-analysis","volume":"12","author":"Gao","year":"2021","journal-title":"Front Pharmacol"},{"key":"R6-20261020","doi-asserted-by":"crossref","first-page":"e001659","DOI":"10.1136\/bmjophth-2024-001659","article-title":"Aflibercept for central retinal vein occlusions: long-term outcomes of a \u201cTreat-and-Extend\u201d regimen","volume":"9","author":"Jaggi","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"R7-20261020","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.oret.2020.12.016","article-title":"Spectral domain OCT predictors of visual acuity in the study of COmparative treatments for REtinal vein occlusion 2: SCORE 2 report 15","volume":"5","author":"Etheridge","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R8-20261020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamaophthalmol.2021.5619","article-title":"Visual outcomes associated with patterns of macular edema resolution in central retinal vein occlusion treated with anti\u2013vascular endothelial growth factor therapy: a post hoc analysis of the Lucentis, Eylea, Avastin in vein occlusion (LEAVO) trial","volume":"140","author":"Gurudas","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R9-20261020","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ophtha.2017.10.031","article-title":"Fully automated detection and quantification of macular fluid in OCT using deep learning","volume":"125","author":"Schlegl","year":"2018","journal-title":"Ophthalmology"},{"key":"R10-20261020","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1167\/tvst.9.2.54","article-title":"Automated segmentation of retinal fluid volumes from structural and angiographic optical coherence tomography using deep learning","volume":"9","author":"Guo","year":"2020","journal-title":"Trans Vis Sci Technol"},{"key":"R11-20261020","doi-asserted-by":"crossref","first-page":"100972","DOI":"10.1016\/j.preteyeres.2021.100972","article-title":"AI-based monitoring of retinal fluid in disease activity and under therapy","volume":"86","author":"Schmidt-Erfurth","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R12-20261020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40942-024-00560-6","article-title":"Analysis of optical coherence tomography biomarker probability detection in central serous chorioretinopathy by using an artificial intelligence-based biomarker detector","volume":"10","author":"Ferro Desideri","year":"2024","journal-title":"Int J Retina Vitreous"},{"key":"R13-20261020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000538543","article-title":"Prediction of chronic central serous chorioretinopathy through combined manual annotation and AI-assisted volume measurement of flat irregular pigment epithelium","volume":"247","author":"Desideri","year":"2024","journal-title":"Ophthalmologica"},{"key":"R14-20261020","doi-asserted-by":"crossref","first-page":"110462","DOI":"10.1016\/j.exer.2025.110462","article-title":"Integration of proteomics and artificial intelligence-driven OCT biomarker analysis in central retinal vein occlusion","volume":"258","author":"Ferro","year":"2025","journal-title":"Exp Eye Res"},{"key":"R15-20261020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s40942-025-00717-x","article-title":"Short and long-term impact of intravitreal anti-VEGF therapy interruption in retinal vein occlusion during the COVID-19 pandemic: functional outcomes and AI-based fluid analysis of macular edema","volume":"11","author":"Moret","year":"2025","journal-title":"Int J Retina Vitreous"},{"key":"R16-20261020","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40942-025-00691-4","article-title":"Faricimab for treatment-resistant choroidal neovascularization (CNV) in neovascular age-related macular degeneration (nAMD): seven-months results using artificial intelligence and OCTA","volume":"11","author":"Heinke","year":"2025","journal-title":"Int J Retina Vitreous"},{"key":"R17-20261020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40942-025-00665-6","article-title":"Early real-world outcomes of intravitreal aflibercept 8 mg in treatment-Na\u00efve neovascular AMD: AI-assisted fluid volume analysis","volume":"11","author":"Cattaneo","year":"2025","journal-title":"Int J Retina Vitreous"},{"key":"R18-20261020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/bjo-2024-325615","article-title":"Fluid fluctuations assessed with artificial intelligence during the maintenance phase impact anti-vascular endothelial growth factor visual outcomes in a multicentre, routine clinical care national age-related macular degeneration database","volume":"109","author":"Martin-Pinardel","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"R19-20261020","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jamaophthalmol.2017.1141","article-title":"Baseline factors associated with 6-Month visual acuity and retinal thickness outcomes in patients with macular edema secondary to central retinal vein occlusion or hemiretinal vein occlusion: SCORE2 study report 4","volume":"135","author":"Scott","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R20-20261020","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.ophtha.2016.01.011","article-title":"Individualized ranibizumab regimen driven by stabilization criteria for central retinal vein occlusion: twelve-month results of the CRYSTAL study","volume":"123","author":"Larsen","year":"2016","journal-title":"Ophthalmology"},{"key":"R21-20261020","first-page":"605","article-title":"Evaluation of hyperreflective foci as a prognostic factor of visual outcome in retinal vein occlusion","volume":"10","author":"Mo","year":"2017","journal-title":"Int J Ophthalmol"},{"key":"R22-20261020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.oret.2018.04.019","article-title":"Association of disorganization of retinal inner layers with ischemic index and visual acuity in central retinal vein occlusion","volume":"2","author":"Berry","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R23-20261020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oret.2018.07.008","article-title":"Disorganization of retinal inner layers and ellipsoid zone disruption predict visual outcomes in central retinal vein occlusion","volume":"3","author":"Chan","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R24-20261020","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12886-022-02575-9","article-title":"Comparison of hyperreflective foci in macular edema secondary to multiple etiologies with spectral-domain optical coherence tomography: an observational study","volume":"22","author":"Zhu","year":"2022","journal-title":"BMC Ophthalmol"},{"key":"R25-20261020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.13.10.21","article-title":"Artificial intelligence-enhanced OCT biomarkers analysis in macula-off rhegmatogenous retinal detachment patients","volume":"13","author":"Ferro Desideri","year":"2024","journal-title":"Transl Vis Sci Technol"},{"key":"R26-20261020","first-page":"281","article-title":"Some methods for classification and analysis of multivariate observations","author":"MacQueen","year":"1967"},{"key":"R27-20261020","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF02289263","article-title":"Who belongs in the family?","volume":"18","author":"Thorndike","year":"1953","journal-title":"Psychometrika"},{"key":"R29-20261020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ophtha.2013.08.038","article-title":"Long-term outcomes in patients with retinal vein occlusion treated with ranibizumab: the RETAIN study","volume":"121","author":"Campochiaro","year":"2014","journal-title":"Ophthalmology"},{"key":"R30-20261020","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40123-023-00734-9","article-title":"Foveal eversion is associated with high persistence of macular edema and visual acuity deterioration in retinal vein occlusion","volume":"12","author":"Arrigo","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"R31-20261020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.oret.2021.12.007","article-title":"Impact of Intra- and subretinal fluid on vision based on volume quantification in the HARBOR trial","volume":"6","author":"Riedl","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R32-20261020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jamaophthalmol.2022.1357","article-title":"Association between visual acuity and residual retinal fluid following intravitreal anti\u2013vascular endothelial growth factor treatment for neovascular age-related macular degeneration: a systematic review and meta-analysis","volume":"140","author":"Patil","year":"2022","journal-title":"JAMA Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004932","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:00:39Z","timestamp":1792530039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0000000000004932"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004932","relation":{},"ISSN":["0275-004X","1539-2864"],"issn-type":[{"value":"0275-004X","type":"print"},{"value":"1539-2864","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,11]]}}}